April 03, 2014
In Re: Aggrenox Antitrust Litigation
Case Number:
3:14-md-02516
Court:
Nature of Suit:
Multi Party Litigation:
Class Action, Multi-district Litigation
Judge:
Firms
- Faruqi & Faruqi
- Hurwitz Sagarin
- Stoll Berne
- Ahern & Associates
- Quinn Connor Weaver
- Cohen Milstein
- Bass Berry
- Norton Rose
- Capozzi Adler
- Levin Sedran
- Ballard Spahr
- Zayas Law Firm
- Carmody Torrance
- Reinhardt Wendorf
- Smith Segura
- Girard Sharp
- McCune Wright
- Garwin Gerstein
- Milberg Coleman
- Cohen Placitella
- Baker & Miller
- Barrett Johnston
- Spector Roseman
- Berger Montague
- Heins Mills
- Miller Shah LLP
- Hayber McKenna
- Pomerantz LLP
- Kenny Nachwalter
- Wiley Rein
- Motley Rice
- DiCello Levitt
- Blank Rome
- Hangley Aronchick
- Hausfeld LLP
- Lockridge Grindal
- Heim Payne
- Shipman & Goodwin
- Odom & Des Roches
- Simmons Hanly
- Hilliard & Shadowen
- Stevens & Lee
- Cowdery Murphy
- Nussbaum Law Group
- Gibson Dunn
- Hagens Berman
- Goodwin Procter
- Brenner Saltzman
- Baker Donelson
- Pullman & Comley
- Jones Day
- Taus Cebulash
- Day Pitney
- Lowey Dannenberg
- Winstead PC
- Zimmerman Reed
- Glancy Prongay
- Connolly Wells
- Lauletta Birnbaum
- Grant & Eisenhofer
- Labaton Keller
- Latham & Watkins
- White & Case
Companies
- CVS Health Corp.
- Florida Blue
- Association for Accessible Medicines
- The Kroger Co.
- The Cigna Group
- Aetna Inc.
- Gyma Laboratories of America Inc.
- BlueCross BlueShield of Tennessee Inc.
- Rite Aid Corp.
- Bi-Lo
- Humana Inc.
- Rochester Drug Cooperative Inc.
- Boehringer Ingelheim Vetmedica Inc.
- International Union of Painters & Allied Trades
- H‑E‑B LP
- Safeway Inc.
- Winn-Dixie Stores, Inc.
- Teva Pharmaceutical Industries Ltd.
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
October 29, 2019
Allergan's $750M Deal Among Pharma's Top Antitrust Payouts
A $750 million settlement this week by Allergan to avert an antitrust trial involving Alzheimer's drug Namenda is among the most eye-popping sums ever shelled out by a drugmaker for allegedly thwarting generic competition.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login